Variant report
Variant | esv21078 |
---|---|
Chromosome Location | chr10:26608229-26611060 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs564563429 | chr10:26608232-26608233 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs376994556 | chr10:26608233-26608234 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs200885532 | chr10:26608249-26608250 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs574862167 | chr10:26608269-26608270 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs187700840 | chr10:26608295-26608296 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs560693641 | chr10:26608298-26608299 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs192547746 | chr10:26608325-26608326 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs529728808 | chr10:26608375-26608376 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs56850688 | chr10:26608376-26608377 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs559667329 | chr10:26608395-26608396 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs528801745 | chr10:26608399-26608400 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs551752533 | chr10:26608429-26608430 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs185142586 | chr10:26608482-26608483 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs56271228 | chr10:26608489-26608490 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs190072031 | chr10:26608501-26608502 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs138638291 | chr10:26608561-26608562 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs143299098 | chr10:26608572-26608573 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs372359764 | chr10:26608575-26608576 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs61397455 | chr10:26608579-26608580 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs142944871 | chr10:26608621-26608622 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs192866947 | chr10:26608623-26608624 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs139297739 | chr10:26608629-26608630 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs60620484 | chr10:26608630-26608631 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs397940003 | chr10:26608634-26608635 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs535256909 | chr10:26608635-26608636 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs558392293 | chr10:26608677-26608678 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs184905090 | chr10:26608691-26608692 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs112440538 | chr10:26608707-26608708 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs560529222 | chr10:26608730-26608731 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs146119234 | chr10:26608767-26608768 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs368730015 | chr10:26608772-26608773 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs188108016 | chr10:26608804-26608805 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs147429077 | chr10:26608830-26608831 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs559912169 | chr10:26608836-26608837 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs534509373 | chr10:26608895-26608896 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs528636927 | chr10:26608899-26608900 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs139152630 | chr10:26608927-26608928 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs577737238 | chr10:26608933-26608934 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs112353918 | chr10:26608940-26608941 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs149918872 | chr10:26608974-26608975 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs144297655 | chr10:26608978-26608979 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs554128383 | chr10:26608982-26608983 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs74507666 | chr10:26608996-26608997 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs546745044 | chr10:26609062-26609063 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs566670057 | chr10:26609066-26609067 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs538411538 | chr10:26609068-26609069 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs148734580 | chr10:26609101-26609102 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs34526122 | chr10:26609111-26609112 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs568844177 | chr10:26609117-26609118 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs74126454 | chr10:26609131-26609132 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Lung cancer | 18438408 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Oral cancer | 21386901 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Esophageal cancer | 21851588 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Behavioral abnormalities | 21522184 | CNVD |
Dysmorphic features | 21522184 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Autism | 21439084 | CNVD |
Maculopathy | 20981449 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Adrenocortical carcinoma | 18281524 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:26608200-26609000 | Enhancers | Pancreas | Pancrea |
2 | chr10:26609000-26610600 | Weak transcription | Pancreas | Pancrea |
3 | chr10:26610600-26610800 | Enhancers | Pancreas | Pancrea |
4 | chr10:26610800-26612600 | Weak transcription | Pancreas | Pancrea |